Bayer warned Wednesday of uncertainty stemming from US tariffs after President Donald Trump threatened to ramp up levies on pharmaceuticals, as the German group reported a hefty loss.

Here is how Amarin (AMRN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

When Bayer CEO Bill Anderson launched his Dynamic Shared Ownership (DSO) layoff plan—designed to save 2 billion euros ($2.3 ...

Chelsea are back in action after a well-earned break following their success in the recently concluded Club World Cup. That ...

Bayer CropScience Ltd on Wednesday reported a 10% increase in its net profit to Rs 278.7 crore for the first quarter of this ...

Malik Tillman is still waiting for his first playing minutes for Bayer Leverkusen. Manager Erik ten Hag gave the German ...

The German giant has already trimmed more than 10,000 employees since initiating a massive restructuring initiative in July ...

Manchester United won't sign Patrik Schick this summer after the striker signed a new deal with Erik ten Hag's ...

La Gazzetta dello Sport reported today that the Magpies made an initial bid for the defender but it was rejected by the ...

Bayer AG (BAYRY) reported second-quarter 2025 core earnings of 35 cents per American Depositary Receipt (ADR), which ...

Speaking in an interview with Sky Sports, Cody Gakpo revealed high expectations for fellow Dutchman Jeremie Frimpong at ...

Trump’s EPA seems bullish on a proposal to deregulate the infamous herbicide, but some foes in Arkansas pledge to keep ...